Loading...

Hikma Pharmaceuticals PLC

HKMPY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$37.21
$0.00(0.00%)
U.S. Market opens in 7h 38m

Hikma Pharmaceuticals PLC (HKMPY) Stock Overview

Explore Hikma Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.1B
P/E Ratio10.20
EPS (TTM)$3.62
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$42.78
3 Months$32.32
1 Year Target$49.94

HKMPY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hikma Pharmaceuticals PLC (HKMPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.20 and a market capitalization of 4.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
5.26%
3-Month Change
-11.34%
6-Month Change
-20.83%
Year-to-Date (YTD) Change
-11.26%
1-Year Change
-30.85%
3-Year Change
-20.12%
5-Year Change
-45.19%
All-Time (Max) Change
53.25%

Contact Information

https://www.hikma.com
44 20 7399 2760
1 New Burlington Place, London, NaN, W1S 2HR

Company Facts

9,500 Employees
IPO DateFeb 7, 2012
CountryGB
Actively Trading

Frequently Asked Questions